| Financial Year |
March 31 2022 |
| Monetary Funds |
465,426,532.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,617,907.60 |
| Accounts Receivable |
2,064,889,755.93 |
| Advances to Suppliers |
117,211,055.61 |
| Other Receivables |
118,137,191.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
450,418,990.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,438,259.99 |
| Other Current Assets |
49,068,482.37 |
| Total Current Assets |
3,287,218,076.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,205,572.09 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,349,252,769.39 |
| Under-construction Projects |
13,443,307.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,436,266.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
77,472,619.96 |
| Other Non-Current Assets |
28,394,967.14 |
| Sub-Total of Non-Current Assets |
2,714,202,310.68 |
| Total Assets |
6,001,420,386.85 |
| Short-Term Loans |
2,128,144,400.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
490,342,188.22 |
| Accounts Received In Advance |
108,998.13 |
| Employee Compensation Payable |
101,144,727.79 |
| Taxes Payable |
23,375,459.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
84,054,187.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,073,808.31 |
| Other Current Liabilities |
22,504,612.85 |
| Sub-Total of Current Liabilities |
2,877,470,486.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,900,607.16 |
| Deferred Income Tax Liabilities |
27,648,490.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,244,847.31 |
| Total Liabilities |
2,936,715,334.11 |
| Paid-In Capital(Or Share Stock) |
929,756,977.00 |
| Capital Surplus |
1,935,397,257.37 |
| Surplus Reserve |
228,811,278.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-33,549,818.48 |
| Minority Stockholder's Interest |
4,289,358.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,060,415,694.64 |
| Owner's Equity（Stockholder's Equity） |
3,064,705,052.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,001,420,386.85 |
